Researchers in Toronto have made advances in developing human progenitor heart cells from embryonic stem cells.
Dr. Gordon Keller, director of the McEwen Center for Regenerative Medicine at the University Health Network reported in the journal Nature the new method of generating the heart cells can be used to make an unlimited supply for researchers to study cell processes and medical applications.
The manufactured heart cells likely will be used to study how the heart develops and to test whether heart medications are toxic, the Toronto Star reported.
"These cells are remarkable ... in that they can make cardiomyocytes, the cells that actually contract, and they can also make cells that contribute to the blood vessels in the heart," Keller said.
His team used two different human embryonic stem cell lines from Singapore and Wisconsin, both approved by Canadian and U.S. oversight agencies, the report said.
The study expanded on work done last year by researchers led by Charles Murry, director of the Center of Cardiovascular Biology at the University of Washington in Seattle, who showed it was possible to turn human embryonic stem cells into heart muscle cells.
Copyright 2008 by United Press International
Related stories:
Researcher develops novel method to grow human embryonic stem cells
(PhysOrg.com) -- The majority of researchers working with human embryonic stem cells (hESCs) – cells which produce any type of specialized adult cells in the human body – use animal-based materials for culturing the cells. But because these materials are animal-based, they could transmit viruses and other pathogens to the hESCs, making the cells unsuitable for medical use.
Scientists identify single microRNA that controls blood vessel development
Scientists from the Gladstone Institute of Cardiovascular Disease (GICD) and UCSF have identified a key regulatory factor that controls development of the human vascular system, the extensive network of arteries, veins, and capillaries that allow blood to reach all tissues and organs. The research, published in the latest issue of
Developmental Cell, may offer clues to potential therapeutic targets for a wide variety of diseases, such as heart disease or cancer, that are impacted by or affect the vascular system.
Researchers grow human blood vessels in mice from adult progenitor cells
For the first time, researchers have successfully grown functional human blood vessels in mice using cells from adult human donors — an important step in developing clinical strategies to grow tissue, researchers report in
Circulation Research: Journal of the American Heart Association.
Gene directs stem cells to build the heart
Researchers have shown that they can put mouse embryonic stem cells to work building the heart, potentially moving medical science a significant step closer to a new generation of heart disease treatments that use human stem cells.
Nerve cells derived from stem cells and transplanted into mice may lead to improved brain treatments
Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in
The Journal of Neuroscience. The research, an important step toward developing new treatments for stroke, Alzheimer's, Parkinson's and other neurological conditions showed that mice afflicted by stroke showed tangible therapeutic improvement following transplantation of these cells. None of the mice formed tumors, which had been a major setback in prior attempts at stem cell transplantation.
Researchers find key developmental pathway activates lung stem cells
Researchers from the University of Pennsylvania School of Medicine found that the activation of a molecular pathway important in stem cell and developmental biology leads to an increase in lung stem cells. Harnessing this knowledge could help develop therapies for lung-tissue repair after injury or disease. The investigators published their findings online last week in advance of print publication in
Nature Genetics.
Caution on stem cell therapy
A single organ may contain more than one type of adult stem cell – a discovery that complicates prospects for using the versatile cells to replace damaged tissue as a treatment for disease, according to a new study from the laboratory of geneticist Mario Capecchi, the University of Utah's Nobel Laureate.
Adult stem cell findings offer new hope for Parkinson's cure
Research released today provides evidence that a cure for Parkinson's disease could lie just inside the nose of patients themselves.